Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
125.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 5.50 (4.622%)
Market Cap: £98.09m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Scheduled Trading Statement

8 Jul 2019 07:00

RNS Number : 7147E
Xaar PLC
08 July 2019
 

Xaar plc

 

Scheduled Trading Statement

 

Xaar plc ("Xaar" or the "Group"), a world leader in industrial inkjet technology, provides its scheduled trading update for the six months ended 30 June 2019.

Trading is in line with the Board's expectations and Xaar expects to report revenue of approximately £23 million for the six months ended 30 June 2019. Overall revenue for the first half was £27 million however this was impacted by approximately £4 million of revenue reversal regarding Xaar 1201 inventory being returned to the business. We anticipate selling this inventory in the second half of the year. Cash at 30 June 2019 was £21.6 million.

Excluding one-time Royalties of approximately £10 million in H1 2018 and the prior years' revenue reversal of approximately £4 million in H1 2019, revenue grew by 8%.

Underlying trading in the Printhead business has stabilised after the declines of 2018 with growth in the Industrial and Packaging segments. Growth in Industrials came from Ceramics, Décor and Advanced Manufacturing, while in Packaging growth came from Coding and Marking. As referenced above, approximately £4 million revenue in the Graphics segment has been reversed due to Xaar 1201 inventory being returned for rework due to age. We have subsequently regained control of this inventory in order to drive payment recovery and explore broader channel options. Key new printhead products have shown good growth in the first half; Xaar 2001 (43%), Xaar 501 (88%) and in particular Xaar 5601 (490%) which continues to be very positively received by customers as recently witnessed at the ITMA textile printing show in Barcelona.

Our Product Print Systems business grew by 41% driven by growth in inkjet and pad printing equipment as well as consumables.

Xaar 3D Printing is on plan with strong positive customer feedback for our new printer and we continue to work closely with Stratasys on the next phase of our partnership.

Cash balances of £21.6 million at 30 June 2019 are in line with expectations, reflecting the improved working capital profile of the business. We continue to work diligently at improving our working capital and anticipate further progress through the second half of the year.

 

We have advanced on our strategic review of the Thin Film business and will provide an update on progress at the half year results due to be announced on 10 September 2019.

 

 

Enquiries:

Xaar plc

+44 (0)1223 423 663 

Doug Edwards, Chief Executive Officer

Shomit Kenkare, Chief Financial Officer

 

 

Tulchan Communications

+44 (0)20 7353 4200

James Macey White

David Ison

 

About XaarXaar is a world leader in the development of digital inkjet technology. Our technology drives the conversion of analogue printing and manufacturing methods to digital inkjet which is more efficient, more economical and more productive than the traditional methods which have been in use for years. We design and manufacture printheads as well as systems for product decoration and industrial 3D Printing which use our inkjet technology. We are the only truly independent inkjet technology company with over 25 years of know how. We offer unrivalled inkjet expertise including technology and printhead design and development, and manufacture highly customised product decoration systems and industrial 3D Printing for volume manufacturing. Our unique technologies and products are the leading enabler for innovation and for driving supply chain efficiencies for many industries. Information about Xaar is at www.xaar.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKDLFBKDFLBBB
Date   Source Headline
27th Aug 20157:01 amRNS2015 Interim Results
26th Aug 20156:01 pmRNSHolding(s) in Company
3rd Aug 201510:25 amRNSTotal Voting Rights
8th Jul 20157:00 amRNSScheduled Trading Statement
7th Jul 20153:28 pmRNSHolding(s) in Company
1st Jul 20151:36 pmRNSBlocklisting Interim Review
1st Jul 20151:33 pmRNSTotal Voting Rights
5th Jun 20157:00 amRNSDirectorate Change
1st Jun 20151:16 pmRNSTotal Voting Rights
1st May 20151:27 pmRNSDirector Shareholding
1st May 201512:37 pmRNSTotal Voting Rights
27th Apr 201510:00 amRNSDirectorate Change
8th Apr 20153:58 pmRNSDirector/PDMR Shareholding
7th Apr 20154:33 pmRNSGrant of Options
7th Apr 20154:31 pmRNSDirector/PDMR Shareholding
31st Mar 20155:23 pmRNSTotal Voting Rights
27th Mar 201510:08 amRNSDirectorate Change
24th Mar 20152:15 pmRNSDirector/PDMR Shareholding
19th Mar 20157:00 amRNS2014 Full Year Results
3rd Mar 20159:51 amRNSTotal Voting Rights
2nd Mar 20157:00 amRNSDirector Appointment
16th Feb 20152:09 pmRNSDirectorate Change
2nd Feb 20155:52 pmRNSTotal Voting Rights
5th Jan 20157:00 amRNSAppointment of CEO
2nd Jan 201510:00 amRNSBlocklisting Interim Review
2nd Jan 201510:00 amRNSTotal Voting Rights
19th Dec 20142:34 pmRNSHolding(s) in Company
17th Dec 20147:00 amRNSTrading Update
16th Dec 20143:58 pmRNSHolding(s) in Company
15th Dec 201411:01 amRNSHolding(s) in Company
12th Dec 20149:31 amRNSHolding(s) in Company
1st Dec 20145:32 pmRNSTotal Voting Rights
27th Nov 20144:22 pmRNSHolding(s) in Company
3rd Nov 201412:34 pmRNSTotal Voting Rights
3rd Nov 201410:01 amRNSHolding(s) in Company
27th Oct 201412:48 pmRNSDirector/PDMR Shareholding
10th Oct 20149:57 amRNSHolding(s) in Company
7th Oct 20144:26 pmRNSHolding(s) in Company
6th Oct 20142:35 pmRNSHolding(s) in Company
3rd Oct 20145:12 pmRNSHolding(s) in Company
2nd Oct 20147:00 amRNSInterim Management Statement
1st Oct 20143:57 pmRNSTotal Voting Rights
30th Sep 20149:12 amRNSGrant of Options - Share Save
16th Sep 20142:56 pmRNSHolding(s) in Company
9th Sep 20143:11 pmRNSHolding(s) in Company
8th Sep 20143:02 pmRNSDirector/PDMR Shareholding
1st Sep 20145:41 pmRNSTotal Voting Rights
28th Aug 20147:00 amRNS2014 Interim Results
1st Aug 20141:11 pmRNSTotal Voting Rights
17th Jul 20147:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.